SlideShare a Scribd company logo
ANTI NEOPLASTIC AGENTS
1By
Nakka varshitha
CONTENTS
INTRODUCTION
HISTORY
EPIDEMIOLOGY
CAUSE
PATHOGENESIS
CLASSIFICATION
DIAGNOSIS
ANTI NEOPLASTICS
AGENTS
2
INTRODUCTION
The medical term for tumor (or) cancer is Neoplasm, Which
means a relatively autonomous growth (or) un corodinated cell
proliferation of body tissue.
CELL PRODUCTION
CELL DEGRADATION
3
HISTORY
 The branch of medicine which deals with the excessive study
of neoplasm (tumor) and its development diagnosis and
treatment is called “Oncology.”
 The term cancer was translated from a Latin word carcino i.e.
Crab by celsus.
 For the first time Hippocrates coined the Greek word
Karkinos i.e. (crab/cray fish) for malignant breast cancer
4
EPIDEMIOLOGY
FEMALE MALE
 Worldwide, it is estimated that about 20% of all deaths are cancer-
related.
 Due to varying etiologic factors, cancers of the cervix and oral cavity
are more common in India while cancers of the breast and lung are
commoner in the Western populations.
5
CAUSES?? 6
PATHOGENESIS
7
PATHOGENESIS
8
SELF SUFFICIENCY IN GROWTH SIGNALS
The mechanisms that endow cancer
cells with the ability to proliferate
can be grouped according to their
role in the growth factor–induced
signal transduction cascade and cell
cycle regulation.They are
 Growth Factors
 Growth Factor Receptors &
Non-ReceptorTyrosine Kinases
 Downstream Signal-Transducing
Proteins
 Nuclear Transcription Factors
 Cyclins and Cyclin-Dependent
Kinases
9
IN SENSITIVE TO ANTI GROWTH SIGNALS
 RB Gene: Governor of the Cell Cycle
 TP53 Gene: Guardian of the Genome
 Transforming Growth Factor-β Pathway
 Contact Inhibition, NF2, and APC
10
EVADING APOPTOSIS
• Apoptosis can be initiated through
extrinsic or intrinsic Pathways. Both
pathways result in the activation of a
proteolytic cascade of caspases that
destroys the cell.
• Mitochondrial outer membrane
permeabilization is regulated by the
balance between pro-apoptotic (e.g.,
BAX,BAK) and anti-apoptotic
molecules (BCL2, BCL-XL). BH-3–
only molecules activate apoptosis by
tilting the balance in favor of the pro-
apoptotic molecules.
11
SUSTAINED ANGIOGENESIS
 Vascularization of tumors is essential for their growth and is
controlled by the balance between angiogenic and
antiangiogenic factors that are produced by tumor and stromal
cells.
 Hypoxia triggers angiogenesis through the actions of HIF-1α
on the transcription of the pro-angiogenic factor
VEGF.Because of its ability to degrade HIF-1α and thereby
prevent angiogenesis, VHL acts as a tumor suppressor.
 Inheritance of germ
line mutations of VHL
causes VHL syndrome,
characterized by the
development of a variety of tumors. 12
LIMITLESS REPLICATIVE
POTENTIAL
 In normal cells, which lack expression of telomerase, the
shortened telomeres generated by cell division eventually
activate cell cycle checkpoints, leading to senescence and
placing a limit on the number of divisions a cell may undergo.
 In cells that have disabled checkpoints, DNA repair pathways
are inappropriately activated by shortened telomeres, leading
to massive chromosomal instability and mitotic crisis.
 Tumor cells reactivate telomerase, thus staving off mitotic
catastrophe and achieving immortality.
13
14
TISSUE INVASION AND
METASTATIS
Ability to invade tissues, a hallmark of malignancy, occurs in
four steps:
 loosening of cell–cell contacts
 Degradation of ECM
 attachment to novel ECM components
 migration of tumor cells
15
CLASSIFICATION

 A disease or a growth that is
likely to get uncontrollably
worse and lead to death
MALIGNANT
TUMOR
• A growth that is not likely to
cause death
BENIGN TUMOR
16
17
TYPES OF CANCERS
 Carcinoma
 Sarcoma
 Leukemia
 Lymphoma
 Blastoma
 Melanoma
 Adenomas
 Gliomas
 Germ cell tumors
18
DIAGNOSIS
 Symptomatic identification
 Lab test
 Imaging procedure
CT scan
Nuclear scan
Ultra sound
MRI
PET scan
X-rays
 Biopsy
Neddle
Endoscopy
Surgery
CT scan Ultra sound PET scan
X-rays mamograph
19
TREATMENT
CHEMOTHERAPHY
SURGEORY
RADIATION
20
Classification of anticancer agents
1.Alkylating agents:-
Nitrogen mustards
• Cyclophosphamide
• Meclorethamine
2.Antimetabolites:-
 purine antagonist:-6-mercaptopurine
 Folic acid antagonist:-methotrexate
 Pyrimidine antagonist:-5-flurouracil
3.Plant products:-
 Vinca alkaloids
 Vincrystine
 vinblastine
21
4.Anti biotics:-
 Doxorubicin
 Actinomycin
5.Hormonal agents:
 Tamoxifen
 Glucocorticosteroids
6.Miscellaneous:-
 Hydroxy urea
 Asparginase
22
Alkylating agents
Alkylation is defined as the replacement of hydrogen on an atom
by an alkyl group.
Nitrogen mustard:-
 Nitrogenmusterds get their name because they related to sulfur
containing mustard gases used during first world war.
 These are unstable as their cytotoxic effect towards the
proliferating cell insists their use.
Structure of cyclophosphamide
Cl
Cl
N P
O
NH
O
It is 2-bis-(2-chloroethyl)amino-
perhydro-1,3,2-
oxazaphosphorinane-2-oxide mono
hydrate.
23
Properties
 Readily soluble in water.
 Melting point- 41-450 c.
 Soluble in alcohol, benzene, ethylene glycol,carbon- tetrachloride,
dioxane.
 It is available in tablets and injections.
Uses
 Treatment of Hodgkin's disease
 Acute lymphocytic leukemia
 Breast,cervix,lung,ovary tumors.
24
25
Meclorethamine
• It is also known as mustine or chlormethethine.
• It is 2-chloro-N-(2-chloroethyl)-N-methylethanmine.
Cl H2C H2C
N
H2CCH2Cl
CH3
26
PropertiesProperties
• Mechlorethamine is available as Hcl salt.
• Mechlorethamine Hcl is white crystalline power.
• It is hygroscopic and freely soluble in water.
Uses
• Hodgkin’s disease
• Other lymphomas
27
Anti metabolites
• Anti metabolites are the agents which inhibit the enzymes involved in
the synthesis of DNA (or)it’s nucleotide building blocks.
• The inhibitors involved are described as antimetabolites generally the
cellular components like folic acids,purines.that are involved in the
synthesis of nucleic acids(DNA,RNA).
• Anti-metabolites inhibits nucleic acids synthesis by competitive
inhibition of cellular components.
28
Purine antagonist:6-mercaptopurine
• It is 1,7-dihydro-6H-purine-6-thione.
N
N
H
N
H
N
S
29
Properties
• It is available as yellow prisms having a decomposion
temperature of 3130c .
• It is insoluble in water, acetone, ether.
• It is soluble in alkali solutions.
Uses
 It has immunosuppressant action.
 It is used in the treatment of acute myelocytic leukemia.
30
Folic acid antagonist: methotrexate
• It is 4-amino-(N10)-methylpteroylglutamic acid.
O
H
N
CO2H
HO2C
N
CH3
H
N
N
H
N
NH2
NH2
31
Mechanism of action
32
properties
 Methyltrexate is available as yellow crystals having a decomposition
temperature of 2040 c.
 It is soluble in alkaline or acidic solutions .
 Insoluble in water.
Uses
 Used in the treatment of gestational choriocarcinoma.
 Trophoblstic tumors of women.
 Acute lympholytic leukemia in children.
 Psoriasis, breast, lung, cancer. 33
Pyrimidine antagonist
5-flurouracil:
It is chemically 5-fluro-2,4(1H,3H) pyrimidienedione.
N
H
NH
O
O
F
34
Properties
 white crystalline power.
 sparingly soluble in water and is a light sensitive compound.
Uses
 used in the tumors.
 used topically in treatment of basal cell carcinomas and premalignant
skin keratoses.
35
Vinca alkaloids
Vinblastine:
• Obtained from “cathranthus roseus”.
• Vinblastine having 2 moites.
1.Catharanthine
2.vindoline
36
Properties
 White to slightly yellow colour crystalline odour less powder.
 Soluble in water, methanol,ethanol,chlorform.
 Insoluble in ether having melting point 2800c.
Uses
 Testicular cancer & ovarian cancer
 Hodgkin’s disease.
 Non-Hodgkin’s lymphoma
 Kaposi’s sarcoma.
37
Vincrystine
• It is also obtained from the “catharanthus roseus”
38
properties
• white to yellow odourless crystals.
• Freely soluble in water, insoluble in ether.
• having melting point 220c.
Uses
• Acute leukemia
• Hodgkin’s lymphoma,
• Burkett's lymphoma,
• Wilm’s tumor
• Brain, lung, breast, head tumors.
39
Anti-biotics
• The cytotoxic nature of antibiotics used in the treatment of cancer.
Actionomycins:
• produced from “streptomyces chrysomallus”.
H
N
NH
Cl
NH3C
H3C
40
Properties
 Bright red rhomboid prisms, having melting point 241-2430c.
 Soluble in alcohol, propylene glycol in mixture of water & glycol.
Mechanism of action
Actinomycins interrelate into double-helical DNA and interfere with it’s
template function.
Uses
 Rabdomyosacroma&wilm’s tumor.
 Uterus & testis tumors.
41
Doxorubicin
Obtained from “streptomycin chrysomallus”
OCH3
OH
O
O
CCH2OH
OH
O
O
H
NH2
H
OH
H
CH3
H
H
O
H
42
Properties
 Orange coloured needles having melting point 204-2050c.
 Soluble in water and aqueous alcohols, methanol.
 Insoluble in acetone, benzene, chloroform, ether.
Uses
 Treatment of leukemia
 Hodgkin’s disease
 Neuroblastoma
 Breast & ovarian cancer
43
Hormonal agents
Adrino cortico steroids:
Prednisone :
Uses
 Adrino Cortico Carcinoma
 Prostatic Carcinoma
C
O
O
O
CH2OH
OH
44
Tamoxifen
H3C
OCH2CH2N(CH3)2
45
Properties
 It is fine, white odorless,
crystalline powder having
melting point of 140
 It is slightly soluble in water
and soluble in ethanol,
methanol and acetone.
Uses
Used in Advanced breast cancer.
Miscellaneous
Asparaginase
Uses
Used in breast cancer.
NH2
C O
CH2
CH CH3N O
O
46
Alternatives For Antineoplastic Agents:
 30% cancers are diet related.
 Dithiolthiones are a group of chemicals in broccoli,
cauliflower, cabbage one of which involves the activation of
enzymes in the liver to detoxify carcinogens.
 Genistein is a protective compound found in soya products.
 Antioxidant present in green tea.
47
CONCLUSION
 Public education campaigns are
important in highlighting the dangers
of smoking, because possibly as
many as 30% of cancers are caused
by smoking, excessive drinking, and
hazardous solvents, as well as
promoting healthy diets and
lifestyles.
 30% of cancers are diet related that’s
why everybody should take healthy
diets and lifestyles.
 The benefits of eating high-fibre
foods, fruit, and vegetables are clear.
 Infact, there have been various
research projects aimed at identifying
the specific chemicals in these foods
which are responsible for this
protective property.
48
49

More Related Content

What's hot

Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapy
Zulcaif Ahmad
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapyraj kumar
 
Chemotherapy of cancer
Chemotherapy of cancerChemotherapy of cancer
Chemotherapy of cancer
balaji college of pharmacy
 
Classification of anti cancer drugs
Classification of anti cancer drugs Classification of anti cancer drugs
Classification of anti cancer drugs
pgclubrcc
 
Veterinary antineoplastic drugs
Veterinary antineoplastic drugsVeterinary antineoplastic drugs
Veterinary antineoplastic drugssuniu
 
Anthracyclines dr. varun
Anthracyclines dr. varunAnthracyclines dr. varun
Anthracyclines dr. varunVarun Goel
 
Anticancer drugs and classification and mechanism of action
Anticancer drugs and classification and mechanism of actionAnticancer drugs and classification and mechanism of action
Anticancer drugs and classification and mechanism of action
Akshaya Kumar
 
Anti neoplastic agents
Anti neoplastic agentsAnti neoplastic agents
Anti neoplastic agents
NAGA PRASHANT KOPPURAVURI
 
Anti cancer drugs
Anti cancer drugsAnti cancer drugs
Anti cancer drugsKalaivani P
 
Oncology
OncologyOncology
Oncology
Drbaig
 
Principles Of Chemotherapy
Principles Of ChemotherapyPrinciples Of Chemotherapy
Principles Of ChemotherapyFrank Bonilla
 
medicinal chemistry of Anticancer agents
medicinal chemistry of Anticancer agentsmedicinal chemistry of Anticancer agents
medicinal chemistry of Anticancer agents
Ganesh Mote
 
Principles of cancer chemotherapy and its clinical evaluation
Principles of cancer chemotherapy and its clinical evaluationPrinciples of cancer chemotherapy and its clinical evaluation
Principles of cancer chemotherapy and its clinical evaluationjyotimannath
 
Medicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsMedicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agents
DHARMENDRA BARIA
 
Anticancer drugs Pharmacology
Anticancer drugs Pharmacology Anticancer drugs Pharmacology
Anticancer drugs Pharmacology
King Angco
 

What's hot (18)

Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapy
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapy
 
Chemotherapy of cancer
Chemotherapy of cancerChemotherapy of cancer
Chemotherapy of cancer
 
Classification of anti cancer drugs
Classification of anti cancer drugs Classification of anti cancer drugs
Classification of anti cancer drugs
 
Veterinary antineoplastic drugs
Veterinary antineoplastic drugsVeterinary antineoplastic drugs
Veterinary antineoplastic drugs
 
Anthracyclines dr. varun
Anthracyclines dr. varunAnthracyclines dr. varun
Anthracyclines dr. varun
 
Anticancer drugs and classification and mechanism of action
Anticancer drugs and classification and mechanism of actionAnticancer drugs and classification and mechanism of action
Anticancer drugs and classification and mechanism of action
 
Anti neoplastic agents
Anti neoplastic agentsAnti neoplastic agents
Anti neoplastic agents
 
Anti Cancer New Program
Anti Cancer New ProgramAnti Cancer New Program
Anti Cancer New Program
 
Anti cancer drugs
Anti cancer drugsAnti cancer drugs
Anti cancer drugs
 
Oncology
OncologyOncology
Oncology
 
Principles Of Chemotherapy
Principles Of ChemotherapyPrinciples Of Chemotherapy
Principles Of Chemotherapy
 
medicinal chemistry of Anticancer agents
medicinal chemistry of Anticancer agentsmedicinal chemistry of Anticancer agents
medicinal chemistry of Anticancer agents
 
Principles of cancer chemotherapy and its clinical evaluation
Principles of cancer chemotherapy and its clinical evaluationPrinciples of cancer chemotherapy and its clinical evaluation
Principles of cancer chemotherapy and its clinical evaluation
 
Anti cancer drugs
Anti cancer drugsAnti cancer drugs
Anti cancer drugs
 
Medicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsMedicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agents
 
Anticancer drugs Pharmacology
Anticancer drugs Pharmacology Anticancer drugs Pharmacology
Anticancer drugs Pharmacology
 
Anticancer
AnticancerAnticancer
Anticancer
 

Similar to Cancer and anti neoplastic agents

MolOncolChemother2015Col.ppt
MolOncolChemother2015Col.pptMolOncolChemother2015Col.ppt
MolOncolChemother2015Col.ppt
ssuserf14ecf
 
anticancer agents
 anticancer agents anticancer agents
anticancer agents
Adhira Ambala
 
Newer Tumour Markers
Newer Tumour MarkersNewer Tumour Markers
Newer Tumour Markers
Bina Gadhiya
 
anti cancer drugs.ppt
anti cancer drugs.pptanti cancer drugs.ppt
anti cancer drugs.ppt
Ilangovan Ponnilavarasan
 
Molecuar Oncological Chemotherpy.ppt
Molecuar Oncological Chemotherpy.pptMolecuar Oncological Chemotherpy.ppt
Molecuar Oncological Chemotherpy.ppt
ShinilLenin
 
Cancer treatment
Cancer treatment Cancer treatment
Cancer treatment
Amany Elsayed
 
CHEMOTHERAPY IN CANCERS
CHEMOTHERAPY IN CANCERSCHEMOTHERAPY IN CANCERS
CHEMOTHERAPY IN CANCERS
Yashveer Singh
 
Anticancer drugs
Anticancer drugsAnticancer drugs
Anticancer drugs
SMS MEDICAL COLLEGE
 
Cancer chemotherapy part I
Cancer chemotherapy part ICancer chemotherapy part I
Cancer chemotherapy part I
Mahatma Gandhi Medical College & Hospital
 
Cancer chemotherapy part i
Cancer chemotherapy part iCancer chemotherapy part i
Cancer chemotherapy part i
Mahatma Gandhi Medical College & Hospital
 
Recent advances in anticancer agents
Recent advances  in anticancer agentsRecent advances  in anticancer agents
Recent advances in anticancer agents
Dipesh Kakadiya
 
CYTOTOXIC DRUGS - Dr Apurva.pptx
CYTOTOXIC DRUGS - Dr Apurva.pptxCYTOTOXIC DRUGS - Dr Apurva.pptx
CYTOTOXIC DRUGS - Dr Apurva.pptx
apurvap23
 
Drugs used in cancer.pptm
Drugs used in cancer.pptmDrugs used in cancer.pptm
Drugs used in cancer.pptm
DEVIN YADAV
 
principles of chemotherapy
principles of chemotherapyprinciples of chemotherapy
principles of chemotherapyDR NILESH KATOLE
 
Anticancer drugs.pptx
Anticancer drugs.pptxAnticancer drugs.pptx
Anticancer drugs.pptx
Dr. Manjoor Ahamad Syed
 
Principles of chemotherapy .pdf
Principles of chemotherapy .pdfPrinciples of chemotherapy .pdf
Principles of chemotherapy .pdf
SaikatChakraborty80
 
Anticancer drugs persentation
Anticancer drugs persentationAnticancer drugs persentation
Anticancer drugs persentation
ROHIT PAL
 
Anticancer agents
Anticancer agents Anticancer agents
Anticancer agents
muthulakshmi623285
 
Anticancer agents in medicinal chemistry
Anticancer agents in medicinal chemistryAnticancer agents in medicinal chemistry
Anticancer agents in medicinal chemistry
muthulakshmi623285
 

Similar to Cancer and anti neoplastic agents (20)

MolOncolChemother2015Col.ppt
MolOncolChemother2015Col.pptMolOncolChemother2015Col.ppt
MolOncolChemother2015Col.ppt
 
anticancer agents
 anticancer agents anticancer agents
anticancer agents
 
Newer Tumour Markers
Newer Tumour MarkersNewer Tumour Markers
Newer Tumour Markers
 
anti cancer drugs.ppt
anti cancer drugs.pptanti cancer drugs.ppt
anti cancer drugs.ppt
 
Molecuar Oncological Chemotherpy.ppt
Molecuar Oncological Chemotherpy.pptMolecuar Oncological Chemotherpy.ppt
Molecuar Oncological Chemotherpy.ppt
 
Cancer treatment
Cancer treatment Cancer treatment
Cancer treatment
 
DCA Poster
DCA PosterDCA Poster
DCA Poster
 
CHEMOTHERAPY IN CANCERS
CHEMOTHERAPY IN CANCERSCHEMOTHERAPY IN CANCERS
CHEMOTHERAPY IN CANCERS
 
Anticancer drugs
Anticancer drugsAnticancer drugs
Anticancer drugs
 
Cancer chemotherapy part I
Cancer chemotherapy part ICancer chemotherapy part I
Cancer chemotherapy part I
 
Cancer chemotherapy part i
Cancer chemotherapy part iCancer chemotherapy part i
Cancer chemotherapy part i
 
Recent advances in anticancer agents
Recent advances  in anticancer agentsRecent advances  in anticancer agents
Recent advances in anticancer agents
 
CYTOTOXIC DRUGS - Dr Apurva.pptx
CYTOTOXIC DRUGS - Dr Apurva.pptxCYTOTOXIC DRUGS - Dr Apurva.pptx
CYTOTOXIC DRUGS - Dr Apurva.pptx
 
Drugs used in cancer.pptm
Drugs used in cancer.pptmDrugs used in cancer.pptm
Drugs used in cancer.pptm
 
principles of chemotherapy
principles of chemotherapyprinciples of chemotherapy
principles of chemotherapy
 
Anticancer drugs.pptx
Anticancer drugs.pptxAnticancer drugs.pptx
Anticancer drugs.pptx
 
Principles of chemotherapy .pdf
Principles of chemotherapy .pdfPrinciples of chemotherapy .pdf
Principles of chemotherapy .pdf
 
Anticancer drugs persentation
Anticancer drugs persentationAnticancer drugs persentation
Anticancer drugs persentation
 
Anticancer agents
Anticancer agents Anticancer agents
Anticancer agents
 
Anticancer agents in medicinal chemistry
Anticancer agents in medicinal chemistryAnticancer agents in medicinal chemistry
Anticancer agents in medicinal chemistry
 

More from varshitha Nakka

Decreased fetal movement
Decreased fetal movementDecreased fetal movement
Decreased fetal movement
varshitha Nakka
 
Evidence based practice
Evidence based practiceEvidence based practice
Evidence based practice
varshitha Nakka
 
hospital formulary
hospital formularyhospital formulary
hospital formulary
varshitha Nakka
 
cluster headaches
 cluster headaches cluster headaches
cluster headaches
varshitha Nakka
 
AMYLODIOSIS
AMYLODIOSISAMYLODIOSIS
AMYLODIOSIS
varshitha Nakka
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
varshitha Nakka
 
Microbiology
MicrobiologyMicrobiology
Microbiology
varshitha Nakka
 
Gout
GoutGout
LABELING AND PACKING OF PARENTRAL PREPARATIONS
LABELING AND PACKING OF PARENTRAL PREPARATIONSLABELING AND PACKING OF PARENTRAL PREPARATIONS
LABELING AND PACKING OF PARENTRAL PREPARATIONS
varshitha Nakka
 

More from varshitha Nakka (9)

Decreased fetal movement
Decreased fetal movementDecreased fetal movement
Decreased fetal movement
 
Evidence based practice
Evidence based practiceEvidence based practice
Evidence based practice
 
hospital formulary
hospital formularyhospital formulary
hospital formulary
 
cluster headaches
 cluster headaches cluster headaches
cluster headaches
 
AMYLODIOSIS
AMYLODIOSISAMYLODIOSIS
AMYLODIOSIS
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Microbiology
MicrobiologyMicrobiology
Microbiology
 
Gout
GoutGout
Gout
 
LABELING AND PACKING OF PARENTRAL PREPARATIONS
LABELING AND PACKING OF PARENTRAL PREPARATIONSLABELING AND PACKING OF PARENTRAL PREPARATIONS
LABELING AND PACKING OF PARENTRAL PREPARATIONS
 

Recently uploaded

Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 

Recently uploaded (20)

Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 

Cancer and anti neoplastic agents

  • 3. INTRODUCTION The medical term for tumor (or) cancer is Neoplasm, Which means a relatively autonomous growth (or) un corodinated cell proliferation of body tissue. CELL PRODUCTION CELL DEGRADATION 3
  • 4. HISTORY  The branch of medicine which deals with the excessive study of neoplasm (tumor) and its development diagnosis and treatment is called “Oncology.”  The term cancer was translated from a Latin word carcino i.e. Crab by celsus.  For the first time Hippocrates coined the Greek word Karkinos i.e. (crab/cray fish) for malignant breast cancer 4
  • 5. EPIDEMIOLOGY FEMALE MALE  Worldwide, it is estimated that about 20% of all deaths are cancer- related.  Due to varying etiologic factors, cancers of the cervix and oral cavity are more common in India while cancers of the breast and lung are commoner in the Western populations. 5
  • 9. SELF SUFFICIENCY IN GROWTH SIGNALS The mechanisms that endow cancer cells with the ability to proliferate can be grouped according to their role in the growth factor–induced signal transduction cascade and cell cycle regulation.They are  Growth Factors  Growth Factor Receptors & Non-ReceptorTyrosine Kinases  Downstream Signal-Transducing Proteins  Nuclear Transcription Factors  Cyclins and Cyclin-Dependent Kinases 9
  • 10. IN SENSITIVE TO ANTI GROWTH SIGNALS  RB Gene: Governor of the Cell Cycle  TP53 Gene: Guardian of the Genome  Transforming Growth Factor-β Pathway  Contact Inhibition, NF2, and APC 10
  • 11. EVADING APOPTOSIS • Apoptosis can be initiated through extrinsic or intrinsic Pathways. Both pathways result in the activation of a proteolytic cascade of caspases that destroys the cell. • Mitochondrial outer membrane permeabilization is regulated by the balance between pro-apoptotic (e.g., BAX,BAK) and anti-apoptotic molecules (BCL2, BCL-XL). BH-3– only molecules activate apoptosis by tilting the balance in favor of the pro- apoptotic molecules. 11
  • 12. SUSTAINED ANGIOGENESIS  Vascularization of tumors is essential for their growth and is controlled by the balance between angiogenic and antiangiogenic factors that are produced by tumor and stromal cells.  Hypoxia triggers angiogenesis through the actions of HIF-1α on the transcription of the pro-angiogenic factor VEGF.Because of its ability to degrade HIF-1α and thereby prevent angiogenesis, VHL acts as a tumor suppressor.  Inheritance of germ line mutations of VHL causes VHL syndrome, characterized by the development of a variety of tumors. 12
  • 13. LIMITLESS REPLICATIVE POTENTIAL  In normal cells, which lack expression of telomerase, the shortened telomeres generated by cell division eventually activate cell cycle checkpoints, leading to senescence and placing a limit on the number of divisions a cell may undergo.  In cells that have disabled checkpoints, DNA repair pathways are inappropriately activated by shortened telomeres, leading to massive chromosomal instability and mitotic crisis.  Tumor cells reactivate telomerase, thus staving off mitotic catastrophe and achieving immortality. 13
  • 14. 14
  • 15. TISSUE INVASION AND METASTATIS Ability to invade tissues, a hallmark of malignancy, occurs in four steps:  loosening of cell–cell contacts  Degradation of ECM  attachment to novel ECM components  migration of tumor cells 15
  • 16. CLASSIFICATION   A disease or a growth that is likely to get uncontrollably worse and lead to death MALIGNANT TUMOR • A growth that is not likely to cause death BENIGN TUMOR 16
  • 17. 17
  • 18. TYPES OF CANCERS  Carcinoma  Sarcoma  Leukemia  Lymphoma  Blastoma  Melanoma  Adenomas  Gliomas  Germ cell tumors 18
  • 19. DIAGNOSIS  Symptomatic identification  Lab test  Imaging procedure CT scan Nuclear scan Ultra sound MRI PET scan X-rays  Biopsy Neddle Endoscopy Surgery CT scan Ultra sound PET scan X-rays mamograph 19
  • 21. Classification of anticancer agents 1.Alkylating agents:- Nitrogen mustards • Cyclophosphamide • Meclorethamine 2.Antimetabolites:-  purine antagonist:-6-mercaptopurine  Folic acid antagonist:-methotrexate  Pyrimidine antagonist:-5-flurouracil 3.Plant products:-  Vinca alkaloids  Vincrystine  vinblastine 21
  • 22. 4.Anti biotics:-  Doxorubicin  Actinomycin 5.Hormonal agents:  Tamoxifen  Glucocorticosteroids 6.Miscellaneous:-  Hydroxy urea  Asparginase 22
  • 23. Alkylating agents Alkylation is defined as the replacement of hydrogen on an atom by an alkyl group. Nitrogen mustard:-  Nitrogenmusterds get their name because they related to sulfur containing mustard gases used during first world war.  These are unstable as their cytotoxic effect towards the proliferating cell insists their use. Structure of cyclophosphamide Cl Cl N P O NH O It is 2-bis-(2-chloroethyl)amino- perhydro-1,3,2- oxazaphosphorinane-2-oxide mono hydrate. 23
  • 24. Properties  Readily soluble in water.  Melting point- 41-450 c.  Soluble in alcohol, benzene, ethylene glycol,carbon- tetrachloride, dioxane.  It is available in tablets and injections. Uses  Treatment of Hodgkin's disease  Acute lymphocytic leukemia  Breast,cervix,lung,ovary tumors. 24
  • 25. 25
  • 26. Meclorethamine • It is also known as mustine or chlormethethine. • It is 2-chloro-N-(2-chloroethyl)-N-methylethanmine. Cl H2C H2C N H2CCH2Cl CH3 26
  • 27. PropertiesProperties • Mechlorethamine is available as Hcl salt. • Mechlorethamine Hcl is white crystalline power. • It is hygroscopic and freely soluble in water. Uses • Hodgkin’s disease • Other lymphomas 27
  • 28. Anti metabolites • Anti metabolites are the agents which inhibit the enzymes involved in the synthesis of DNA (or)it’s nucleotide building blocks. • The inhibitors involved are described as antimetabolites generally the cellular components like folic acids,purines.that are involved in the synthesis of nucleic acids(DNA,RNA). • Anti-metabolites inhibits nucleic acids synthesis by competitive inhibition of cellular components. 28
  • 29. Purine antagonist:6-mercaptopurine • It is 1,7-dihydro-6H-purine-6-thione. N N H N H N S 29
  • 30. Properties • It is available as yellow prisms having a decomposion temperature of 3130c . • It is insoluble in water, acetone, ether. • It is soluble in alkali solutions. Uses  It has immunosuppressant action.  It is used in the treatment of acute myelocytic leukemia. 30
  • 31. Folic acid antagonist: methotrexate • It is 4-amino-(N10)-methylpteroylglutamic acid. O H N CO2H HO2C N CH3 H N N H N NH2 NH2 31
  • 33. properties  Methyltrexate is available as yellow crystals having a decomposition temperature of 2040 c.  It is soluble in alkaline or acidic solutions .  Insoluble in water. Uses  Used in the treatment of gestational choriocarcinoma.  Trophoblstic tumors of women.  Acute lympholytic leukemia in children.  Psoriasis, breast, lung, cancer. 33
  • 34. Pyrimidine antagonist 5-flurouracil: It is chemically 5-fluro-2,4(1H,3H) pyrimidienedione. N H NH O O F 34
  • 35. Properties  white crystalline power.  sparingly soluble in water and is a light sensitive compound. Uses  used in the tumors.  used topically in treatment of basal cell carcinomas and premalignant skin keratoses. 35
  • 36. Vinca alkaloids Vinblastine: • Obtained from “cathranthus roseus”. • Vinblastine having 2 moites. 1.Catharanthine 2.vindoline 36
  • 37. Properties  White to slightly yellow colour crystalline odour less powder.  Soluble in water, methanol,ethanol,chlorform.  Insoluble in ether having melting point 2800c. Uses  Testicular cancer & ovarian cancer  Hodgkin’s disease.  Non-Hodgkin’s lymphoma  Kaposi’s sarcoma. 37
  • 38. Vincrystine • It is also obtained from the “catharanthus roseus” 38
  • 39. properties • white to yellow odourless crystals. • Freely soluble in water, insoluble in ether. • having melting point 220c. Uses • Acute leukemia • Hodgkin’s lymphoma, • Burkett's lymphoma, • Wilm’s tumor • Brain, lung, breast, head tumors. 39
  • 40. Anti-biotics • The cytotoxic nature of antibiotics used in the treatment of cancer. Actionomycins: • produced from “streptomyces chrysomallus”. H N NH Cl NH3C H3C 40
  • 41. Properties  Bright red rhomboid prisms, having melting point 241-2430c.  Soluble in alcohol, propylene glycol in mixture of water & glycol. Mechanism of action Actinomycins interrelate into double-helical DNA and interfere with it’s template function. Uses  Rabdomyosacroma&wilm’s tumor.  Uterus & testis tumors. 41
  • 42. Doxorubicin Obtained from “streptomycin chrysomallus” OCH3 OH O O CCH2OH OH O O H NH2 H OH H CH3 H H O H 42
  • 43. Properties  Orange coloured needles having melting point 204-2050c.  Soluble in water and aqueous alcohols, methanol.  Insoluble in acetone, benzene, chloroform, ether. Uses  Treatment of leukemia  Hodgkin’s disease  Neuroblastoma  Breast & ovarian cancer 43
  • 44. Hormonal agents Adrino cortico steroids: Prednisone : Uses  Adrino Cortico Carcinoma  Prostatic Carcinoma C O O O CH2OH OH 44
  • 45. Tamoxifen H3C OCH2CH2N(CH3)2 45 Properties  It is fine, white odorless, crystalline powder having melting point of 140  It is slightly soluble in water and soluble in ethanol, methanol and acetone. Uses Used in Advanced breast cancer.
  • 46. Miscellaneous Asparaginase Uses Used in breast cancer. NH2 C O CH2 CH CH3N O O 46
  • 47. Alternatives For Antineoplastic Agents:  30% cancers are diet related.  Dithiolthiones are a group of chemicals in broccoli, cauliflower, cabbage one of which involves the activation of enzymes in the liver to detoxify carcinogens.  Genistein is a protective compound found in soya products.  Antioxidant present in green tea. 47
  • 48. CONCLUSION  Public education campaigns are important in highlighting the dangers of smoking, because possibly as many as 30% of cancers are caused by smoking, excessive drinking, and hazardous solvents, as well as promoting healthy diets and lifestyles.  30% of cancers are diet related that’s why everybody should take healthy diets and lifestyles.  The benefits of eating high-fibre foods, fruit, and vegetables are clear.  Infact, there have been various research projects aimed at identifying the specific chemicals in these foods which are responsible for this protective property. 48
  • 49. 49